Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Deviation Management in Quality Assurance – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Deviation Management in Quality Assurance – V 2.0

Standard Operating Procedure for Deviation Management in Quality Assurance


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/084/2025
Supersedes SOP/SIM/084/2022
Page No. Page 1 of 14
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

To establish a standard procedure for identifying, documenting, investigating, and resolving deviations encountered in processes, systems, or documentation related to sterile injectable manufacturing operations, ensuring consistent product quality and regulatory compliance.

2. Scope

This SOP applies to all planned and unplanned deviations observed in manufacturing, packaging, quality

control, quality assurance, and warehouse operations within the sterile injectable manufacturing unit.

3. Responsibilities

  • Initiator: Identifies and reports deviation by filling out the deviation form.
  • QA Executive: Logs, reviews, investigates, and tracks deviations; ensures CAPA initiation.
  • Department Head: Provides investigation support and ensures CAPA implementation.
  • QA Manager: Reviews and approves investigation and CAPA; decides on batch disposition.
See also  Sterile Injectable Manufacturing: SOP for Handling and Storage of Packaging Materials - V 2.0

4. Accountability

Head – Quality Assurance is accountable for effective deviation management, ensuring closure within the stipulated time and compliance with GMP standards.

5. Procedure

5.1 Deviation Identification and Initiation

  1. Deviation may be identified during any operation, audit, or quality check.
  2. The concerned person must inform the supervisor and QA immediately.
  3. Fill out the Deviation Form (Annexure-1) and submit to QA within 24 hours of detection.

5.2 Deviation Logging and Numbering

  1. QA assigns a unique deviation number in the Deviation Register (Annexure-2).
  2. Number format: DEV/DEPT/XXX/YY (e.g., DEV/MFG/045/25).

5.3 Deviation Classification

  1. QA classifies deviations as:
    • Critical: May affect product quality/safety.
    • Major: Significant process/documentation lapses with potential indirect impact.
    • Minor: Low-risk procedural lapses.

5.4 Investigation and Impact Assessment

  1. QA, along with the department head, conducts root cause analysis using tools such as 5-Why or Fishbone diagram.
  2. Assess product impact, batch status, and regulatory reporting requirement.
  3. Document findings in Deviation Investigation Report (Annexure-3).
See also  Sterile Injectable Manufacturing: SOP for In-Process Checks during Packaging Operations - V 2.0

5.5 Corrective and Preventive Actions (CAPA)

  1. Responsible person proposes CAPA using CAPA Form (Annexure-4).
  2. QA verifies and tracks CAPA implementation within 30 days.
  3. Re-train employees where required and update related SOPs.

5.6 Deviation Closure

  1. QA reviews CAPA completion and effectiveness check.
  2. Update Deviation Closure Status Log (Annexure-5).
  3. Deviation must be closed within 30 working days. If not, justify with reasons and revised timeline.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • CAPA: Corrective and Preventive Action
  • GMP: Good Manufacturing Practices

7. Documents

  1. Deviation Form – Annexure-1
  2. Deviation Register – Annexure-2
  3. Deviation Investigation Report – Annexure-3
  4. CAPA Form – Annexure-4
  5. Deviation Closure Status Log – Annexure-5

8. References

  • WHO TRS 986 Annex 2 – GMP Guidelines
  • ICH Q9 – Quality Risk Management
  • 21 CFR Part 211 – Subpart F (Production and Process Controls)
See also  Quality Control: SOP for Analyzing Residual Solvents in Injectable Formulations - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Deviation Form

Deviation No. DEV/MFG/045/25
Date 10/06/2025
Department Manufacturing
Description pH meter calibration missed
Initiator Rajesh Kumar

Annexure-2: Deviation Register

Deviation No. Date Department Status
DEV/MFG/045/25 10/06/2025 Manufacturing Open

Annexure-3: Deviation Investigation Report

Root Cause Missed schedule in calendar
Impact None, instrument not used
Investigator Sunita Reddy

Annexure-4: CAPA Form

Corrective Action Re-train staff
Preventive Action Setup alert system for calibration
Responsible Person Anita Mehta

Annexure-5: Deviation Closure Status Log

Deviation No. Closure Date Verified By Status
DEV/MFG/045/25 25/06/2025 QA Officer Closed

Revision History

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial version New SOP implementation QA Head
18/06/2025 2.0 Updated with annexures and CAPA workflow Annual review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Aerosol: SOP for Ensuring Propellant Purity During Storage and Use – V 2.0
Next Post: Analytical Method Development: SOP for TGA Method for Moisture and Volatile Content – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version